BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1648290)

  • 1. [Medicamentous modification of gastrointestinal motility and secretion].
    Allescher HD
    Z Gastroenterol; 1991 Apr; 29 Suppl 3():27-30. PubMed ID: 1648290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders.
    Peeters TL
    Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT4 receptor agonists: similar but not the same.
    De Maeyer JH; Lefebvre RA; Schuurkes JA
    Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
    Weber FH; Richards RD; McCallum RW
    Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCK1 antagonists: are they ready for clinical use?
    Peter SA; D'Amato M; Beglinger C
    Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motilin and ghrelin as prokinetic drug targets.
    De Smet B; Mitselos A; Depoortere I
    Pharmacol Ther; 2009 Aug; 123(2):207-23. PubMed ID: 19427331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motility disorders in the ICU: recent therapeutic options and clinical practice.
    Röhm KD; Boldt J; Piper SN
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders].
    Peeters TL
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):349-54. PubMed ID: 1926941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pharmacologic therapies in gastrointestinal disease.
    Wallace JL; Ferraz JG
    Gastroenterol Clin North Am; 2010 Sep; 39(3):709-20. PubMed ID: 20951926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Megens AA; Awouters FH; Niemegeers CJ
    Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachykinin receptors as drug targets for motility disorders.
    Hoogerwerf WA; Sarna SK
    Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prokinetic drugs].
    Hellström P
    Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the possibility of using prokinetics in gastroenterology].
    Sheptulin AA; Vize-Khripunova MA
    Klin Med (Mosk); 2010; 88(5):19-22. PubMed ID: 21089451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of gastrointestinal motor disorders.
    Schuurkes JA
    Rev Gastroenterol Mex; 1994; 59(2):165-70. PubMed ID: 7991970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.